- Note that their other ibodies do not go straight to the liver, and a reminder that we are waiting on 2 more targets to be identified this calendar yr.
- Forums
- ASX - By Stock
- Ann: AD-214 pathway to IPF efficacy studies
1AD
adalta limited
Add to My Watchlist
0.00%
!
0.2¢

Note that their other ibodies do not go straight to the liver,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600006 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 600000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1138005 | 0.003 |
26 | 25099399 | 0.002 |
15 | 40453497 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 600000 | 1 |
0.003 | 9196667 | 17 |
0.004 | 13062108 | 11 |
0.005 | 2946002 | 7 |
0.006 | 1963830 | 1 |
Last trade - 09.55am 25/06/2025 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
Day chart unavailable